| Intravascular Large B-Cell Lymphoma Masquerading as Cerebral Amyloid Angiopathy-Related Inflammation | Stroke | | | 2026 | 3 | 0 |
|
| Encompassing the Complexity of Personality to Understand its Association with Disability in Multiple Sclerosis | Journal of health psychology | | | 2026 | 1 | 13 |
|
| Investigating neuroanatomical correlates of neuropathic pain in multiple sclerosis : A pilot comparative study using advanced MRI techniques | Revue neurologique | | | 2025 | 38 | 1 |
|
| Inflammatory predictors of Post-COVID fatigue | Brain, behavior, & immunity. Health | | | 2025 | 15 | 34 |
|
| Systemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infection | Scientific reports | | | 2024 | 68 | 197 |
|
| High-dose glucocorticoids in COVID-19 patients with acute encephalopathy: clinical and imaging findings in a retrospective cohort study | Journal of neural transmission | | | 2024 | 114 | 120 |
|
| Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection : A follow-up assessment of the Geneva COVID-COG cohort | Journal of global health | | | 2024 | 130 | 171 |
|
| Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort | Archives of clinical neuropsychology | | | 2023 | 501 | 467 |
|
| Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV ‐2 infection | Human brain mapping | | | 2023 | 285 | 214 |
|
| Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection | Psychoneuroendocrinology | | | 2023 | 210 | 179 |
|
| Personality as a Predictor of Disability in Multiple Sclerosis | Archives of clinical neuropsychology | | | 2023 | 252 | 260 |
|
| Markers of limbic system damage following SARS-CoV-2 infection | Brain communications | | | 2023 | 275 | 119 |
|
| Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse | | | 2023 | 198 | 202 |
|
| Paroxysmal painful tonic spasms in neuromyelitis optica spectrum disorder | eNeurologicalSci | | | 2023 | 65 | 143 |
|
| Obstructive sleep apnea: a major risk factor for COVID-19 encephalopathy? | BMC neurology | | | 2023 | 90 | 148 |
|
| Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case–control study | Sexually transmitted infections | | | 2023 | 178 | 0 |
|
| Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis | JAMA neurology | | | 2023 | 138 | 0 |
|
| c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models | Biomedicines | | | 2023 | 62 | 265 |
|
| Paraneoplastic Autoimmune Limbic Encephalitis Associated with an Atypical Carcinoid Tumor of the Lung : A Case Report | Case reports in neurology | | | 2023 | 123 | 228 |
|
| A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients | Journal of magnetic resonance imaging | | | 2023 | 116 | 177 |
|
| Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase | Brain, behavior, & immunity. Health | | | 2022 | 249 | 300 |
|
| Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | | | 2022 | 253 | 232 |
|
| Prognostic biomarkers in primary progressive multiple sclerosis : Validating and scrutinizing multimodal evoked potentials | Clinical neurophysiology | | | 2022 | 43 | 185 |
|
| Long COVID neuropsychological deficits after severe, moderate or mild infection | Clinical and translational neuroscience | | | 2022 | 625 | 837 |
|
| Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis | JAMA neurology | | | 2022 | 247 | 539 |
|
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | | | 2022 | 239 | 200 |
|
| Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant? | Brain communications | | | 2022 | 427 | 372 |
|
| Answer to Letter to the Editor: High-resolution Black Blood Vessel Wall Imaging in COVID-19 Encephalopathy-is it Really Endotheliitis? | Clinical neuroradiology | | | 2022 | 187 | 56 |
|
| The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19 | Neurodegenerative diseases | | | 2022 | 132 | 368 |
|
| CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation | Journal of neuroinflammation | | | 2022 | 240 | 139 |
|
| Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis | Microbiology spectrum | | | 2022 | 228 | 499 |
|
| Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP | Neurology: Neuroimmunology & Neuroinflammation | | | 2021 | 921 | 525 |
|
| Rabies vaccination and multiple sclerosis relapse: A retrospective cohort study | Multiple Sclerosis and Related Disorders | | | 2021 | 354 | 213 |
|
| COVID‐19 encephalopathy: Clinical and neurobiological features | Journal of Medical Virology | | | 2021 | 355 | 461 |
|
| c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells | Cellular & Molecular Immunology | | | 2021 | 341 | 260 |
|
| Live vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit-risk assessment for natalizumab | Journal of Travel Medicine | | | 2021 | 239 | 1 |
|
| C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy | Journal of neural transmission | | | 2021 | 371 | 128 |
|
| Neuropathie des petites fibres dans les maladies autoimmunes systémiques | Revue médicale suisse | | | 2021 | 912 | 1 |
|
| Does Endothelial Vulnerability in OSA Syndrome Promote COVID-19 Encephalopathy? | Chest | | | 2021 | 186 | 104 |
|
| Cerebrovascular Complications and Vessel Wall Imaging in COVID-19 Encephalopathy—A Pilot Study | Clinical Neuroradiology | | | 2021 | 296 | 173 |
|
| Cerebrospinal Fluid Features in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive Patients | Clinical infectious diseases | | | 2021 | 253 | 283 |
|
| Update in immunosuppressive therapy of myasthenia gravis | Autoimmunity reviews | | | 2021 | 53 | 451 |
|
| Encéphalopathie aiguë et Covid-19: hypothèses physiopathologiques | Revue médicale suisse | | | 2021 | 249 | 361 |
|
| Management of patients with generalised myasthenia gravis and COVID-19 : four case reports | Journal of neurology, neurosurgery and psychiatry | | | 2020 | 37 | 0 |
|
| Unusual Microbleeds in Brain MRI of Covid-19 Patients | Journal of Neuroimaging | | | 2020 | 878 | 516 |
|
| Risk of MS relapse after yellow fever vaccination: A self-controlled case series | Neurology: Neuroimmunology & Neuroinflammation | | | 2020 | 259 | 214 |
|
| SARS‐CoV‐2 and Guillain–Barré syndrome : AIDP variant with a favourable outcome | European journal of neurology | | | 2020 | 61 | 146 |
|
| c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells | Journal of neuroinflammation | | | 2020 | 4 | 3 |
|
| COVID-19-related encephalopathy responsive to high-dose glucocorticoids | Neurology | | | 2020 | 230 | 1 |
|
| Serum neurofilament light chains in MS: Association with the Timed Up and Go | Neurology Neuroimmunology & Neuroinflammation | | | 2020 | 245 | 70 |
|
| IL-8 as a potential biomarker in Guillain-Barre Syndrome | European Cytokine Network | | | 2019 | 279 | 1 |
|
| Encephalitis and meningoencephalitis: chasing the culprit | Clinical Microbiology and Infection | | | 2019 | 310 | 173 |
|
| Pachymeningitis with optic neuropathy associated with extrapulmonary tuberculosis and secondary antiphospholipid syndrome | Multiple Sclerosis and Related Disorders | | | 2019 | 385 | 0 |
|
| AQP4 antibody-positive NMO spectrum disorder associated with Takayasu arteritis | Journal of the Neurological Sciences | | | 2019 | 305 | 1 |
|
| Diagnostic tools for immune causes of encephalitis | Clinical microbiology and infection | | | 2019 | 419 | 2 |
|
| Fulminant multifocal relapse in a fingolimod-treated multiple sclerosis patient | Multiple Sclerosis and Related Disorders | | | 2019 | 442 | 2 |
|
| In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay | Bio-protocol | | | 2018 | 332 | 643 |
|
| Syndrome de Guillain-Barré | Revue médicale suisse | | | 2018 | 699 | 876 |
|
| Activation of human B cells negatively regulates TGF-β1 production | Journal of Neuroinflammation | | | 2017 | 599 | 328 |
|
| Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients | Journal of Neuroinflammation | | | 2017 | 587 | 321 |
|
| Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis | Annals of Neurology | | | 2017 | 613 | 0 |
|
| Does fear of falling predict gait variability in multiple sclerosis? | Journal of the Neurological Sciences | | | 2017 | 643 | 0 |
|
| Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosis | Journal of the Neurological Sciences | | | 2017 | 686 | 3 |
|
| Gait Profile Score in multiple sclerosis patients with low disability | Gait & Posture | | | 2017 | 597 | 1 |
|
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports | | | 2017 | 602 | 4 |
|
| Upper limb movement analysis during gait in multiple sclerosis patients | Human movement science | | | 2017 | 568 | 0 |
|
| [Paraneoplastic neurological syndromes: an update] | Revue médicale suisse | | | 2016 | 521 | 0 |
|
| Sclérose en plaques de forme primaire progressive : un traitement se révèle enfin efficace | Revue médicale suisse | | | 2016 | 614 | 8 |
|
| Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen | Acta neuropathologica | | | 2016 | 568 | 0 |
|
| Multiple sclerosis relapse mimicking a transient ischemic attack | Multiple sclerosis and related disorders | | | 2016 | 587 | 1 |
|
| Postural control is associated with cognition and fear of falling in patients with multiple sclerosis | Journal of neural transmission | | | 2016 | 530 | 0 |
|
| Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability | Journal of neural transmission | | | 2016 | 668 | 1 |
|
| Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling | Journal of neural transmission | | | 2016 | 589 | 0 |
|
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | | | 2016 | 637 | 6 |
|
| B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation | Scientific reports | | | 2016 | 631 | 326 |
|
| Meningoencephalitis with microinfarcts in early neuroborreliosis | Neuroradiology | | | 2016 | 564 | 1 |
|
| A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients | Multiple sclerosis | | | 2015 | 652 | 1 |
|
| Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS | Neurology® neuroimmunology & neuroinflammation | | | 2015 | 488 | 0 |
|
| Minimal supportive treatment in natalizumab-related PML in a MS patient | Journal of neurology, neurosurgery and psychiatry | | | 2015 | 557 | 0 |
|
| A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up | Journal of neuroimmunology | | | 2015 | 606 | 1 |
|
| Hepatocyte growth factor: A regulator of inflammation and autoimmunity | Autoimmunity reviews | | | 2015 | 568 | 0 |
|
| Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study | Neurology® neuroimmunology & neuroinflammation | | | 2015 | 494 | 400 |
|
| Transient gadolinium leakage in natalizumab-treated multiple sclerosis | Journal of neurology, neurosurgery and psychiatry | | | 2015 | 483 | 0 |
|
| Successful long-term ambulatory norepinephrine infusions in a patient with pure autonomic failure | Clinical autonomic research | | | 2015 | 540 | 0 |
|
| Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques | Revue médicale suisse | | | 2015 | 697 | 5 |
|
| Glatiramer acetate treatment negatively regulates type I interferon signaling | Neurology® neuroimmunology & neuroinflammation | | | 2015 | 479 | 1 |
|
| Multifocal motor neuropathy with high titers of anti-MAG antibodies | Journal of the peripheral nervous system | | | 2014 | 560 | 0 |
|
| Update on multiple sclerosis treatments | Schweizerische medizinische Wochenschrift | | | 2014 | 519 | 1 |
|
| Fingolimod in a patient with Wolff-Parkinson-White syndrome | Multiple sclerosis | | | 2014 | 451 | 0 |
|
| The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells | Journal of neuroimmunology | | | 2014 | 555 | 0 |
|
| Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells | The Journal of immunology | | | 2014 | 700 | 3 |
|
| Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients | European neurology | | | 2014 | 721 | 4 |
|
| 18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals | Stroke | | | 2014 | 719 | 3 |
|
| Walking while talking in patients with multiple sclerosis: the impact of specific cognitive loads | Neurophysiologie clinique | | | 2014 | 658 | 3 |
|
| Traitement de la sclérose en plaques : nouveautés et complications | Revue médicale suisse | | | 2013 | 498 | 0 |
|
| Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases | PloS one | | | 2013 | 771 | 591 |
|
| Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) | Revue médicale suisse | | | 2013 | 461 | 0 |
|
| Maladies auto-immunes neuromusculaires : diagnostic et prise en charge | Revue médicale suisse | | | 2013 | 479 | 0 |
|
| The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity | Journal of neuroinflammation | | | 2013 | 634 | 412 |
|
| Neuroborréliose, méningo-encéphalite verno-estivale et neurosyphilis | Revue médicale suisse | | | 2013 | 453 | 465 |
|
| Nogo-A downregulation improves insulin secretion in mice | Diabetes | | | 2013 | 711 | 357 |
|
| [Head inflammation] | Revue médicale suisse | | | 2013 | 413 | 0 |
|
| Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosis | European neurology | | | 2012 | 769 | 0 |
|
| IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis | Journal of neuroinflammation | | | 2012 | 730 | 368 |
|
| Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients | PloS one | | | 2012 | 696 | 280 |
|
| Hypereosinophilia in patients with multiple sclerosis treated with natalizumab | Neurology | | | 2011 | 733 | 0 |
|
| Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis | Journal of neuroinflammation | | | 2011 | 657 | 356 |
|
| Antibody response in MOG35–55 induced EAE | Journal of neuroimmunology | | | 2011 | 771 | 951 |
|
| Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? | Archives of neurology | | | 2011 | 714 | 0 |
|
| Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action | CNS drugs | | | 2011 | 610 | 0 |
|
| Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children | Multiple sclerosis | | | 2011 | 596 | 0 |
|
| Biomarqueurs en neuroimmunologie | Revue médicale suisse | | | 2011 | 544 | 1 |
|
| Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease | PloS one | | | 2010 | 770 | 865 |
|
| VGKC antibody-associated encephalitis, microbleeds and progressive brain atrophy | Journal of neurology | | | 2010 | 715 | 361 |
|
| Glatiramer acetate triggers PI3Kdelta/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes | Proceedings of the National Academy of Sciences of the United States of America | | | 2010 | 711 | 0 |
|
| Behaviorally spontaneous confabulation in limbic encephalitis: the roles of reality filtering and strategic monitoring | Journal of the International Neuropsychological Society | | | 2010 | 701 | 0 |
|
| MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity | The Journal of experimental medicine | | | 2010 | 705 | 1 |
|
| Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells | Proceedings of the National Academy of Sciences of the United States of America | | | 2010 | 728 | 0 |
|
| Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis | Proceedings of the National Academy of Sciences of the United States of America | | | 2009 | 649 | 0 |
|
| Peripheral autoimmune neuropathy assessed using corneal in vivo confocal microscopy | Archives of neurology | | | 2009 | 665 | 0 |
|
| Anomalous brain dominance and the immune system: do left-handers have specific immunological patterns? | Brain and cognition | | | 2009 | 703 | 0 |
|
| Increasing the diagnostic value of evoked potentials in multiple sclerosis by quantitative topographic analysis of multichannel recordings | Journal of clinical neurophysiology | | | 2009 | 715 | 2 |
|
| Autoanticorps en neurologie : implications cliniques | Revue médicale suisse | | | 2009 | 561 | 0 |
|
| Syndrome of transient headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with recent human herpesvirus-6 infection | Cephalalgia | | | 2009 | 711 | 1 |
|
| Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients | Journal of neuroimmunology | | | 2008 | 679 | 0 |
|
| Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model | International immunology | | | 2008 | 650 | 1 |
|
| Human herpesvirus-6 variant A encephalomyelitis | Neurology | | | 2008 | 678 | 0 |
|
| Autoantibodies in inflammatory demyelinating diseases of the central nervous system | Schweizerische medizinische Wochenschrift | | | 2008 | 610 | 4 |
|
| TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse | Behavioral neuroscience | | | 2002 | 526 | 0 |
|
| Encéphalopathie complexe, transitoire et récidivante après résection étendue de l'intestin grêle. Responsabilité du D-Lactate | Revue neurologique | | | 2001 | 600 | 0 |
|
| Lower limb corticobasal degeneration | European neurology | | | 2000 | 570 | 0 |
|
